ADHD Trial, Recruiting (NCT07380412)

ADHD Trial, Recruiting NCT07380412 Sponsor: Outliers, Inc. Condition: ADHD

Printed from Voxsanity (voxsanity.com.au) — NCT07380412 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Adhd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 55 years old
You are currently taking a prescribed stimulant medication for ADHD
You are experiencing some of the following: trouble sleeping, irritability, anxiety, or mental fogginess ("brain fog")
Your ADHD medication dose has stayed the same for at least 3 months
You are generally healthy with no long-term health conditions that are currently unmanaged
If you take any supplements, your routine has been consistent for at least 3 months
You currently live in the United States
You are willing to keep your current lifestyle habits the same during the trial

Who may not be able to join:

You have a long-term (chronic) health condition, such as cancer or a mental illness
You take any psychiatric or mental health medications other than your stimulant
You are pregnant, breastfeeding, or have a thyroid, liver, or kidney condition
You have smoked recently or drink alcohol heavily
You work night shifts
You are currently taking part in another clinical trial
You have known allergies to any of the ingredients in the trial product (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 4242450284

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07380412

Sponsor: Outliers, Inc.

Phase: Not Applicable

Status: Recruiting

Condition: ADHD

Trial contact: 4242450284

More information: https://clinicaltrials.gov/study/NCT07380412

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 55 years old
You are currently taking a prescribed stimulant medication for ADHD
You are experiencing some of the following: trouble sleeping, irritability, anxiety, or mental fogginess ("brain fog")
Your ADHD medication dose has stayed the same for at least 3 months
You are generally healthy with no long-term health conditions that are currently unmanaged
If you take any supplements, your routine has been consistent for at least 3 months
You currently live in the United States
You are willing to keep your current lifestyle habits the same during the trial

Who may not be able to join:

You have a long-term (chronic) health condition, such as cancer or a mental illness
You take any psychiatric or mental health medications other than your stimulant
You are pregnant, breastfeeding, or have a thyroid, liver, or kidney condition
You have smoked recently or drink alcohol heavily
You work night shifts
You are currently taking part in another clinical trial
You have known allergies to any of the ingredients in the trial product (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Outliers, Inc.

Registry

ClinicalTrials.gov

Start date

12 August 2025

Est. completion

1 March 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in oxidative stress and cortisol levels as measured by hs-CRP, 8-OHdG; Change in cortisol levels

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov